Cosmos Health (NASDAQ:COSM) CEO Grigorios Siokas Buys 291,262 Shares

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas acquired 291,262 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The shares were acquired at an average cost of $0.41 per share, for a total transaction of $119,417.42. Following the completion of the transaction, the chief executive officer directly owned 8,473,382 shares of the company’s stock, valued at $3,474,086.62. The trade was a 3.56% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link.

Grigorios Siokas also recently made the following trade(s):

• On Friday, January 23rd, Grigorios Siokas bought 90,325 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.50 per share, with a total value of $45,162.50.
• On Tuesday, January 20th, Grigorios Siokas purchased 353,321 shares of Cosmos Health stock. The shares were bought at an average cost of $0.50 per share, for a total transaction of $176,660.50.
• On Wednesday, January 14th, Grigorios Siokas purchased 493,495 shares of Cosmos Health stock. The stock was bought at an average price of $0.45 per share, with a total value of $222,072.75.
• On Monday, January 12th, Grigorios Siokas acquired 113,185 shares of Cosmos Health stock. The shares were bought at an average cost of $0.50 per share, with a total value of $56,592.50.
• On Thursday, January 8th, Grigorios Siokas acquired 156,190 shares of Cosmos Health stock. The shares were bought at an average price of $0.52 per share, for a total transaction of $81,218.80.
• On Wednesday, January 7th, Grigorios Siokas bought 124,880 shares of Cosmos Health stock. The stock was bought at an average price of $0.52 per share, for a total transaction of $64,937.60.
• On Tuesday, January 6th, Grigorios Siokas bought 133,953 shares of Cosmos Health stock. The stock was bought at an average cost of $0.54 per share, with a total value of $72,334.62.
• On Friday, December 19th, Grigorios Siokas bought 88,314 shares of Cosmos Health stock. The shares were bought at an average price of $0.49 per share, with a total value of $43,273.86.
• On Monday, December 15th, Grigorios Siokas purchased 168,472 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.42 per share, for a total transaction of $70,758.24.
• On Friday, November 28th, Grigorios Siokas purchased 76,360 shares of Cosmos Health stock. The stock was purchased at an average price of $0.64 per share, for a total transaction of $48,870.40.

Cosmos Health Stock Performance

Shares of COSM opened at $0.37 on Friday. The firm has a market capitalization of $13.97 million, a P/E ratio of -0.50 and a beta of 5.36. The company has a debt-to-equity ratio of 0.25, a current ratio of 0.99 and a quick ratio of 0.84. Cosmos Health Inc. has a one year low of $0.28 and a one year high of $1.32. The business has a fifty day moving average of $0.49 and a 200 day moving average of $0.73.

Cosmos Health (NASDAQ:COSM) last announced its earnings results on Friday, November 14th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.16). The firm had revenue of $17.11 million during the quarter, compared to analysts’ expectations of $16.40 million. Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%. As a group, sell-side analysts anticipate that Cosmos Health Inc. will post -0.78 EPS for the current year.

Institutional Trading of Cosmos Health

An institutional investor recently raised its position in Cosmos Health stock. Renaissance Technologies LLC grew its stake in shares of Cosmos Health Inc. (NASDAQ:COSM) by 260.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 334,575 shares of the company’s stock after buying an additional 241,775 shares during the period. Renaissance Technologies LLC owned 0.89% of Cosmos Health worth $167,000 at the end of the most recent reporting period. 12.61% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Cosmos Health in a report on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company has an average rating of “Sell”.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.